MedPath

LEO-158968

Generic Name
LEO-158968

A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968

Phase 1
Recruiting
Conditions
Gout Flares
Joint Pain
Joint Inflammation
Interventions
First Posted Date
2024-06-06
Last Posted Date
2025-05-02
Lead Sponsor
LEO Pharma
Target Recruit Count
15
Registration Number
NCT06444867
Locations
🇬🇧

LEO Pharma Investigational Site, London, United Kingdom

Investigating the Safety of LEO 158968 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
First Posted Date
2023-01-12
Last Posted Date
2025-05-02
Lead Sponsor
LEO Pharma
Target Recruit Count
120
Registration Number
NCT05682352
Locations
🇳🇱

LEO Pharma Investigational Site, Groningen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath